Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BHMT | Q93088 | 6/20 | 0.62 |
| ▸ | ARG1 | P05089 | 1/20 | 0.62 |
| ▸ | ARG2 | P78540 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | NOS2 | P35228 | 3/20 | 0.55 |
| ▸ | NOS1 | P29475 | 2/20 | 0.55 |
| ▸ | NOS3 | P29474 | 1/20 | 0.55 |
| ▸ | GRM8 | O00222 | 2/20 | 0.54 |
| ▸ | GRM6 | O15303 | 2/20 | 0.54 |
| ▸ | GRM7 | Q14831 | 2/20 | 0.54 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.54 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.54 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.54 |
| ▸ | GSR | P00390 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.54 |
| ▸ | GRM5 | P41594 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1867969 | 1.00 | BHMT (0.62) | BHMTARG1ARG2KMT2ALMNA | |
| SCHEMBL7292563 | 0.90 | BHMT (0.62) | BHMTARG1ARG2KMT2ALMNA | |
| SCHEMBL7292565 | 0.90 | BHMT (0.62) | BHMTARG1ARG2KMT2ALMNA | |
| SCHEMBL15436097 | 0.90 | BHMT (0.62) | BHMTARG1ARG2KMT2ALMNA | |
| SCHEMBL17361240 | 0.88 | ARG1 (0.69) | BHMTARG1ARG2NOS2NOS1 | |
| SCHEMBL17361239 | 0.88 | ARG1 (0.69) | BHMTARG1ARG2NOS2NOS1 | |
| SCHEMBL6230471 | 0.88 | BHMT (0.71) | BHMTARG1ARG2KMT2ALMNA | |
| SCHEMBL6230473 | 0.88 | BHMT (0.71) | BHMTARG1ARG2KMT2ALMNA | |
| SCHEMBL1106818 | 0.84 | ARG1 (0.60) | BHMTARG1ARG2KMT2ANOS2 | |
| SCHEMBL4242586 | 0.84 | ARG1 (0.60) | BHMTARG1ARG2KMT2ANOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116120936-B | Etching liquid medicine and preparation method and application thereof | 上海天承化学有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-116120936-A | Etching liquid medicine and preparation method and application thereof | 上海天承化学有限公司 | 2023-05-16 | — | — | CN | claimed |
| CN-114438190-A | Opening and closing nerve soothing soup-autism core effect gene target and screening method thereof | 中国人民解放军空军军医大学 | 2022-05-06 | — | — | CN | claimed |
| US-20260083852-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | UNIV CALIFORNIA (US) | 2026-03-26 | — | — | US | disclosed |
| US-12485182-B2 | Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-12-02 | — | — | US | disclosed |
| WO-2025083208-A1 | SYNTHESIS OF MORPHOLINE DERIVATIVES AND COMPOUNDS THEREFORE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2025-04-24 | — | — | WO | disclosed |
| US-20240366543-A1 | METHODS OF TREATING METHYLMALONIC ACIDEMIA AND PROPIONIC ACIDEMIA | HEMOSHEAR THERAPEUTICS INC (US) | 2024-11-07 | — | — | US | disclosed |
| CN-116120936-B | Etching liquid medicine and preparation method and application thereof | 上海天承化学有限公司 | 2024-06-25 | — | — | CN | disclosed |
| EP-4319746-A1 | METHODS OF TREATING METHYLMALONIC ACIDEMIA AND PROPIONIC ACIDEMIA | Hemoshear Therapeutics, Inc. (US) | 2024-02-14 | — | — | EP | disclosed |
| US-20230346960-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-11-02 | — | — | US | disclosed |
| WO-2023164127-A1 | PET FOOD COMPOSITIONS AND METHODS FOR MODIFYING STOOL QUALITY | MARS, INCORPORATED (US) | 2023-08-31 | — | — | WO | disclosed |
| US-20090022862-A1 | Method to limit acrylamide in heated foods | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2009-01-22 | — | — | US | disclosed |
| WO-2006017526-A2 | METHOD TO LIMIT ACRYLAMIDE IN HEATED FOODS | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2006-02-16 | — | — | WO | disclosed |
| CN-1479715-A | Amides for inhibiting interleukin 8-induced chemotaxis of neutrophils | ��ķ�ɷ�����˾ | 2004-03-03 | — | — | CN | disclosed |
| EP-0373339-B1 | Silver halide recording material | AGFA GEVAERT AG (DE) | 1994-05-04 | — | — | EP | disclosed |
| US-5204326-A | Analgesics, antiulcer agents, lowering calcium absorption | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-04-20 | — | — | US | disclosed |
| US-5089381-A | SILVER HALIDE RECORDING MATERIAL | AGFA-GEVAERT AG (DE) | 1992-02-18 | — | — | US | disclosed |
| EP-0397985-A1 | Polypeptide (calcitonin) derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1990-11-22 | — | — | EP | disclosed |
| EP-0373339-A1 | Silver halide recording material | Agfa-Gevaert AG (DE) | 1990-06-20 | — | — | EP | disclosed |
| EP-0330241-A2 | Calcitonin derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1989-08-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230346960-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | PDGFA, PDGFRB, TEK | BHMT 4465/4885ARG1 700/4885ARG2 1744/4885 |
| US-12485182-B2 | Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair | PDGFA, PDGFRB, TEK | BHMT 4465/4885ARG1 700/4885ARG2 1744/4885 |
| US-20240366543-A1 | METHODS OF TREATING METHYLMALONIC ACIDEMIA AND PROPIONIC ACIDEMIA | MMAB, OTC, ME2 | BHMT 184/4885ARG1 1222/4885ARG2 351/4885 |
| US-20260083852-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | PDGFA, DCLRE1A, PDGFRA | BHMT 3732/4885ARG1 557/4885ARG2 1295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.